QA: Meridian Bioscience INC in us_medicinal_products/2009

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000794172_2010_Meridian_Bioscience_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.19731062629321744, 'aggregate_val': 154785000, 'exp_sum': 192833000, 'exp_to_value': {'AssetsCurrent': 94020000, 'AssetsNoncurrent': 38048000, 'PropertyPlantAndEquipmentNet': 22717000, 'Goodwill': 36809000, 'remainder_Assets': 1239000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.10538328755025148, 'aggregate_val': 155997000, 'exp_sum': 174373000, 'exp_to_value': {'AssetsCurrent': 117147000, 'AssetsNoncurrent': 18376000, 'PropertyPlantAndEquipmentNet': 20474000, 'Goodwill': 17183000, 'remainder_Assets': 1193000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}

Graph

Absolute values for 0000794172, Meridian Bioscience INC

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 16,752,000
2 remainder_Liabilities 0
3 AssetsCurrent 117,147,000
4 AssetsNoncurrent 18,376,000
5 PropertyPlantAndEquipmentNet 20,474,000
6 Goodwill 17,183,000
7 remainder_Assets -17,183,000
8 GeneralAndAdministrativeExpense 35,576,000
9 ResearchAndDevelopmentExpense 8,428,000
10 remainder_Expenses 72,055,000
11 remainder_Revenues 148,274,000
12 remainder_NetIncome 544,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 16,752,000
1 Assets 155,997,000
2 Expenses 116,059,000
3 Revenues 148,274,000
4 StockholdersEquity 139,245,000
5 NetIncome 32,759,000
6 ComprehensiveNetIncome 32,759,000
7 BaseVar 218,813,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.59
9 EconomicCapitalRatio 2.78

Edgar->Model Mapping

Feature Distribution